Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
FDMT
$11.41
-4.68%
Analyze
1M
+36.0%
3M
+149.7%
1Y
+40.0%
Market Cap:
$532.88M
4D Molecular Therapeutics Inc
Healthcare |
Biotechnology
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California.
Click "Analyze" to generate stock analysis
FDMT Price Trend and Signals
FDMT Option Volumes & Open Interests (aggregated)
FDMT Put Call Ratios and IV (aggregated)
FDMT Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-27
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-24
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-20
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-16
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-14
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-13
Somewhat Bullish
price_signal
Yearly high detected.